看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -12.7x - -14.1x | -13.4x |
| Selected Fwd P/E Multiple | -28.7x - -31.7x | -30.2x |
| Fair Value | HK$ 5.67 - HK$ 6.27 | HK$ 5.97 |
| Upside | 18.1% - 30.5% | 24.3% |
| Benchmarks | - | Full Ticker |
| Shanghai HeartCare Medical Technology Corporation Limited | 660,900.0% | SEHK:6609 |
| LifeTech Scientific Corporation | 130,200.0% | SEHK:1302 |
| Angelalign Technology Inc. | 669,900.0% | SEHK:6699 |
| Acotec Scientific Holdings Limited | 666,900.0% | SEHK:6669 |
| Xiangyu Medical Co.,Ltd | 68,862,600.0% | SHSE:688626 |
| Peijia Medical Limited | 999,600.0% | SEHK:9996 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 6609 | 1302 | 6699 | 6669 | 688626 | 9996 | |||
| SEHK:6609 | SEHK:1302 | SEHK:6699 | SEHK:6669 | SHSE:688626 | SEHK:9996 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | 16.8% | 4.1% | 17.7% | -4.3% | NM- | ||
| 3Y CAGR | NM- | 6.8% | -35.4% | NM- | -20.0% | NM- | ||
| Latest Twelve Months | 76.2% | -24.8% | -77.3% | 260.9% | -54.4% | 52.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -300.7% | 24.4% | 13.8% | -3.9% | 30.6% | -1768.7% | ||
| Prior Fiscal Year | -109.5% | 29.6% | 3.6% | 3.1% | 30.5% | -162.6% | ||
| Latest Fiscal Year | -40.5% | 20.8% | 4.5% | 9.8% | 13.9% | -89.0% | ||
| Latest Twelve Months | -17.8% | 19.4% | 4.5% | 9.8% | 13.9% | -48.6% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -8.7x | 16.7x | 73.1x | 32.6x | 42.4x | -8.5x | ||
| Price / LTM Sales | 4.5x | 5.4x | 4.6x | 3.9x | 7.7x | 5.7x | ||
| LTM P/E Ratio | -25.1x | 28.0x | 103.1x | 39.7x | 55.2x | -11.7x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -25.1x | 39.7x | 103.1x | |||||
| Historical LTM P/E Ratio | -14.1x | -11.2x | -7.1x | |||||
| Selected P/E Multiple | -12.7x | -13.4x | -14.1x | |||||
| (x) LTM Net Income | (252) | (252) | (252) | |||||
| (=) Equity Value | 3,209 | 3,378 | 3,547 | |||||
| (/) Shares Outstanding | 654.6 | 654.6 | 654.6 | |||||
| Implied Value Range | 4.90 | 5.16 | 5.42 | |||||
| FX Rate: CNY/HKD | 0.9 | 0.9 | 0.9 | Market Price | ||||
| Implied Value Range (Trading Cur) | 5.25 | 5.52 | 5.80 | 4.80 | ||||
| Upside / (Downside) | 9.3% | 15.0% | 20.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 6609 | 1302 | 6699 | 6669 | 688626 | 9996 | |
| Value of Common Equity | 1,134 | 6,838 | 1,251 | 2,141 | 5,682 | 2,937 | |
| (/) Shares Outstanding | 38.1 | 4,630.6 | 170.0 | 313.4 | 155.6 | 654.6 | |
| Implied Stock Price | 29.72 | 1.48 | 7.36 | 6.83 | 36.51 | 4.49 | |
| FX Conversion Rate to Trading Currency | 0.93 | 0.93 | 0.13 | 0.93 | 1.00 | 0.93 | |
| Implied Stock Price (Trading Cur) | 31.80 | 1.58 | 57.20 | 7.31 | 36.51 | 4.80 | |
| Trading Currency | HKD | HKD | HKD | HKD | CNY | HKD | |
| FX Rate to Reporting Currency | 0.93 | 0.93 | 0.13 | 0.93 | 1.00 | 0.93 | |